Philip Beale
- Oncology top 0.5%
- Metal complexes synthesis and properties 51
- Colorectal Cancer Treatments and Studies 31
- Cancer Treatment and Pharmacology 24
- Cancer survivorship and care 15
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment 27
- Geriatrics and Gerontology top 1%
- Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments 15
-
- Ferrocene Chemistry and Applications 30
-
- Palliative Care and End-of-Life Issues 16
- Co-authors
- Stephen ClarkeFazlul HuqJun YuIan JudsonJane ReadTrevor W. HambleyMatthew D. HallPhyllis Butow
- Journals
- Journal of Clinical Oncology (34 papers)British Journal of Cancer (10 papers)Cancer Chemotherapy and Pharmacology (9 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Philip Beale
216 papers receiving 5.8k citations
Peers
Comparison fields: 5 of 157
- Oncology 2.8k
- Reproductive Medicine 651
- Geriatrics and Gerontology 228
- Obstetrics and Gynecology 379
- Pulmonary and Respiratory Medicine 1.1k
Countries citing papers authored by Philip Beale
This map shows the geographic impact of Philip Beale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Beale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Beale more than expected).
Fields of papers citing papers by Philip Beale
This network shows the impact of papers produced by Philip Beale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Beale. The network helps show where Philip Beale may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philip Beale, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 13 | |
| 6 | 2022 | 1 | |
| 7 | 2017 | 56 | |
| 8 | ICON7: Final overall survival results in the GCIG phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer | 2013 | 21 |
| 9 | ICON7: FINAL OVERALL SURVIVAL RESULTS IN THE GCIG PHASE III RANDOMISED TRIAL OF BEVACIZUMAB IN NEWLY DIAGNOSED OVARIAN CANCER | 2013 | 6 |
| 10 | 2013 | 21 | |
| 11 | Studies on combination of platinum drugs cisplatin and oxaliplatin with phytochemicals anethole and curcumin in ovarian tumour models. | 2012 | 38 |
| 12 | Synergism from the combination of oxaliplatin with selected phytochemicals in human ovarian cancer cell lines. | 2011 | 24 |
| 13 | ICON7: A PHASE III RANDOMISED GYNAECOLOGIC CANCER INTERGROUP TRIAL OF CONCURRENT BEVACIZUMAB AND CHEMOTHERAPY FOLLOWED BY MAINTENANCE BEVACIZUMAB, VERSUS CHEMOTHERAPY ALONE IN WOMEN WITH NEWLY DIAGNOSED EPITHELIAL OVARIAN (EOC), PRIMARY PERITONEAL (PPC) OR FALLOPIAN TUBE CANCER (FTC) | 2010 | 34 |
| 14 | Patient-doctor communication: use of complementary and alternative medicine by adult patients with cancer. | 2010 | 33 |
| 15 | 2009 | 167 | |
| 16 | 2009 | 4 | |
| 17 | Studies on the synthesis and characterization, and binding with DNA of two Cis-Planaramineplatinum(II) complexes of the forms: Cis-PtL2Cl2 and Cis-PtL(NH3)Cl2 and where L=3-Hydroxypyridine and Imidazo(1,2-a) Pyridine | 2006 | 5 |
| 18 | 2003 | 132 | |
| 19 | 2003 | 12 | |
| 20 | Phase I trial of ZD9331 given as a 30 minute infusion on days 1 and 8 with cycles repeated every 3 weeks | 1998 | 2 |
About Philip Beale
Philip Beale is a scholar working on Oncology, Reproductive Medicine and Geriatrics and Gerontology, having authored 227 papers that have together received 5.9k indexed citations. Recurring topics across this work include Metal complexes synthesis and properties (51 papers), Colorectal Cancer Treatments and Studies (31 papers), Ferrocene Chemistry and Applications (30 papers), Ovarian cancer diagnosis and treatment (27 papers), Cancer Treatment and Pharmacology (24 papers), Palliative Care and End-of-Life Issues (16 papers), Cancer survivorship and care (15 papers) and Endometrial and Cervical Cancer Treatments (15 papers). The work is most often cited by research in Oncology (2.8k citations), Reproductive Medicine (651 citations) and Geriatrics and Gerontology (228 citations). Philip Beale has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Stephen Clarke, Fazlul Huq, Jun Yu, Ian Judson, Jane Read, Trevor W. Hambley, Matthew D. Hall, Phyllis Butow, Martin R. Stockler and Fazlul Huq. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Cancer Chemotherapy and Pharmacology, European Journal of Cancer and Journal of Inorganic Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.